BioTime, Inc. today announced a nonexclusive License Agreement between BioTime's subsidiary ES Cell International Pte Ltd and Beckman Research Institute of the City of Hope through which ESI's clinical-grade human embryonic stem cells will be manufactured and provided to BRICOH's clinical collaborators, including medical research organizations intent on using the hES cells to develop and commercialize therapeutic products to treat human disease.
http://ift.tt/1buJAtZ
No comments:
Post a Comment